Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Anti-infectives
Biosimilars
Cell therapy
Drug delivery
Gene therapy
Nucleic acid drugs
Small molecule therapeutics
Immunotherapy
Antibody-drug-conjugate
Indications
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 158
On the market: 6
Description
Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company engaged in the discovery, development, licensing manufacturing, marketing, distribution, and sale of medicines and related medical products to patients with serious diseases. The company's primary focus is on cancer, cardiovascular, immunology, and fibrotic therapeutic projects. The company researches to focus on discovering and developing novel medicines that address serious diseases in areas of significant unmet medical...
